First Horizon Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
First Horizon Advisors's CRL Position: Q2 2025 in Review
First Horizon Advisors reduced its Charles River Laboratories (CRL) stake by 47% in Q2 2025, selling an estimated $14.1K and leaving 118 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.
First Horizon Advisors first reported a position in CRL in Q4 2020 and has held it in 19 quarters since. The position peaked at $82.4K in Q1 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.
- First Horizon Advisors held 118 shares of Charles River Laboratories worth $17.9K as of Q2 2025.
- First Horizon Advisors sold 106 Charles River Laboratories shares in Q2 2025, an estimated $14.1K.
- Charles River Laboratories made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1464 holding.
- First Horizon Advisors first reported a position in Charles River Laboratories in Q4 2020 and has held it in 19 quarters since.
- First Horizon Advisors's Charles River Laboratories position peaked at $82.4K in Q1 2024.
- 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.